Recurrent Squamous Cell Carcinoma of the Hypopharynx Withdrawn Phase 1 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0029504 (Recurrent Squamous Cell Carcinoma of the Hypopharynx)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01728480Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyTreatment